Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dexamethasone 0.7 MG

 
National Institutes of Health

Related topics

Related topics

2 relations
DexamethasoneDexamethasone 0.7 MG Drug Implant [Ozurdex]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
Purpose To report our experience with bilateral placement of dexamethasone 0.7 mg (DEX) sustained-release intravitreal implant in… Expand
  • table 2
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2012
2012
Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
Purpose: To report the effective treatment of radiation macular edema following ruthenium-106 plaque brachytherapy for a… Expand
  • figure 1
  • figure 2
2012
2012
Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg
We report the case of a 62-year-old woman with a history of vitreoretinal surgery for vitreous hemorrhage secondary to central… Expand
  • figure 1
  • figure 2
2011
2011
Fast Resolution of Recurrent Pronounced Macular Edema following Intravitreal Injection of Dexamethasone 0.7 mg
Purpose: To report the fast resolution of recurrent pronounced macular edema due to central retinal vein occlusion (CRVO) within… Expand
  • figure 1
  • figure 2
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE